• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Kato Yasuhiro  加藤 保宏

ORCIDConnect your ORCID iD *help
Researcher Number 30837050
Other IDs
Affiliation (Current) 2025: 大阪大学, 大学院医学系研究科, 助教
Affiliation (based on the past Project Information) *help 2022 – 2023: 大阪大学, 大学院医学系研究科, 助教
2021: 大阪大学, 医学系研究科, 助教
2019 – 2020: 大阪大学, 医学系研究科, 特任助教(常勤)
Review Section/Research Field
Principal Investigator
Basic Section 54020:Connective tissue disease and allergy-related
Keywords
Principal Investigator
membrane vesicles / type I IFN / AdMVs / reporter cell assay / PPR / mRNA vaccine / COVID-19 / 自己免疫疾患 / Type I IFN / STING / SLE
  • Research Projects

    (2 results)
  • Research Products

    (4 results)
  •  Apoptosis由来膜小胞に着目したCOVID-19重症化メカニズムの解明Principal Investigator

    • Principal Investigator
      加藤 保宏
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54020:Connective tissue disease and allergy-related
    • Research Institution
      Osaka University
  •  Elucidation of the pathogenesis of SLE based on characterisation of patient-derived membrane vesicles.Principal Investigator

    • Principal Investigator
      Kato Yasuhiro
    • Project Period (FY)
      2019 – 2023
    • Research Category
      Grant-in-Aid for Early-Career Scientists
    • Review Section
      Basic Section 54020:Connective tissue disease and allergy-related
    • Research Institution
      Osaka University

All 2023

All Journal Article Presentation

  • [Journal Article] Efficacy and risk of mRNA vaccination in patients with autoimmune inflammatory rheumatic diseases2023

    • Author(s)
      Kato Yasuhiro、Morita Takayoshi、Kumanogoh Atsushi
    • Journal Title

      Inflammation and Regeneration

      Volume: 43 Issue: 1

    • DOI

      10.1186/s41232-022-00247-1

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-22K16344
  • [Journal Article] Persistence of SARS-CoV-2 neutralizing antibodies and anti-Omicron IgG induced by BNT162b2 mRNA vaccine in patients with autoimmune inflammatory rheumatic disease: an explanatory study in Japan2023

    • Author(s)
      Yamaguchi Y、Nameki S、Kato Y、Saita R、Sato T、Nagao S、Murakami T、Yoshimine Y、Amiya S、Morita T、Okita Y、Kawasaki T、Fujimoto J、Ueda Y、Maeda Y、Watanabe A、Takamatsu H、Nishida S、Shima Y、Narazaki M、Kumanogoh A
    • Journal Title

      The Lancet Regional Health - Western Pacific

      Volume: 32 Pages: 100661-100661

    • DOI

      10.1016/j.lanwpc.2022.100661

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21J12329, KAKENHI-PROJECT-22K16344
  • [Presentation] 新型コロナワクチンによる 免疫応答の研究の今2023

    • Author(s)
      加藤保宏
    • Organizer
      日本ヒューマンヘルスケア学会
    • Data Source
      KAKENHI-PROJECT-22K16344
  • [Presentation] リウマチ性疾患患者における SARS-CoV-2 mRNA ワクチン効果の持続性2023

    • Author(s)
      行木紳一郎, 山口勇太, 加藤保宏, 村上輝明, 吉峰由子, 網屋沙織, 森田貴義, 沖田康孝 川崎貴裕, 藤本潤, 前田悠一, 渡邊あかね, 高松漂太, 西田純幸, 嶋良仁, 楢崎雅司, 熊ノ郷淳
    • Organizer
      臨床免疫学会
    • Data Source
      KAKENHI-PROJECT-22K16344

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi